1
|
Maris JM and Matthay KK: Molecular biology
of neuroblastoma. J Clin Oncol. 17:2264–2279. 1999.PubMed/NCBI
|
2
|
Aronson MR, Smoker WR and Oetting GM:
Hemorrhagic intracranial parenchymal metastases from primary
retroperitoneal neuroblastoma. Pediatr Radiol. 25:284–285. 1995.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Ara T and DeClerck YA: Mechanisms of
invasion and metastasis in human neuroblastoma. Cancer Metastasis
Rev. 25:645–657. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ciccarone V, Spengler BA, Meyers MB,
Biedler JL and Ross RA: Phenotypic diversification in human
neuroblastoma cells: expression of distinct neural crest lineages.
Cancer Res. 49:219–225. 1989.PubMed/NCBI
|
5
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Mantovani A, Marchesi F, Portal C,
Allavena P and Sica A: Linking inflammation reactions to cancer:
novel targets for therapeutic strategies. Adv Exp Med Biol.
610:112–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mantovani A, Garlanda C and Allavena P:
Molecular pathways and targets in cancer-related inflammation. Ann
Med. 42:161–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Hu M and Polyak K: Microenvironmental
regulation of cancer development. Curr Opin Genet Dev. 18:27–34.
2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Giavazzi R, Garofalo A, Bani MR, et al:
Interleukin 1-induced augmentation of experimental metastases from
a human melanoma in nude mice. Cancer Res. 50:4771–4775.
1990.PubMed/NCBI
|
13
|
Ditsworth D and Zong WX: NF-kappaB: key
mediator of inflammation-associated cancer. Cancer Biol Ther.
3:1214–1216. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Helbig G, Christopherson KW 2nd,
Bhat-Nakshatri P, et al: NF-kappaB promotes breast cancer cell
migration and metastasis by inducing the expression of the
chemokine receptor CXCR4. J Biol Chem. 278:21631–21638. 2003.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Baggiolini M, Dewald B and Moser B: Human
chemokines: an update. Annu Rev Immunol. 15:675–705. 1997.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Rot A and von Andrian UH: Chemokines in
innate and adaptive host defense: basic chemokinese grammar for
immune cells. Annu Rev Immunol. 22:891–928. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Vicari AP and Caux C: Chemokines in
cancer. Cytokine Growth Factor Rev. 13:143–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sun X, Cheng G, Hao M, et al:
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer
Metastasis Rev. 29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Wang J, Sun Y, Song W, Nor JE, Wang CY and
Taichman RS: Diverse signaling pathways through the SDF-1/CXCR4
chemokine axis in prostate cancer cell lines leads to altered
patterns of cytokine secretion and angiogenesis. Cell Signal.
17:1578–1592. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Geminder H, Sagi-Assif O, Goldberg L, et
al: A possible role for CXCR4 and its ligand, the CXC chemokine
stromal cell-derived factor-1, in the development of bone marrow
metastases in neuroblastoma. J Immunol. 167:4747–4757. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Tabyaoui I, Tahiri-Jouti N, Serhier Z, et
al: Immunohistochemical expression of CD44s in human neuroblastic
tumors: Moroccan experience and highlights on current data. Diagn
Pathol. 8(39): 2013
|
26
|
Lu Y, Jeong YT, Li X, et al: Emodin
isolated from Polygoni cuspidati radix inhibits TNF-α and IL-6
release by blockading NF-κB and MAP kinase pathways in mast cells
stimulated with PMA plus A23187. Biomol Ther (Seoul). 21:435–441.
2013. View Article : Google Scholar
|
27
|
Hong GE, Kim JA, Nagappan A, et al:
Flavonoids identified from Korean Scutellaria baicalensis Georgi
inhibit inflammatory signaling by suppressing activation of NF-κB
and MAPK in RAW 264.7 cells. Evid Based Complement Alternat Med.
2013(912031): 2013
|
28
|
Dai L, Gu L, Ding C, Qiu L and Di W: TWEAK
promotes ovarian cancer cell metastasis via NF-kappaB pathway
activation and VEGF expression. Cancer Lett. 283:159–167. 2009.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Aggarwal BB: Nuclear factor-kappaB: the
enemy within. Cancer Cell. 6:203–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Shishodia S and Aggarwal BB: Nuclear
factor-kappaB activation mediates cellular transformation,
proliferation, invasion angiogenesis and metastasis of cancer.
Cancer Treat Res. 119:139–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ahn KS and Aggarwal BB: Transcription
factor NF-kappaB: a sensor for smoke and stress signals. Ann NY
Acad Sci. 1056:218–233. 2005. View Article : Google Scholar
|
32
|
Karin M: NF-kappaB as a critical link
between inflammation and cancer. Cold Spring Harb Perspect Biol.
1:a0001412009. View Article : Google Scholar
|
33
|
Okera M, Bae K, Bernstein E, et al:
Evaluation of nuclear factor kappaB and chemokine receptor CXCR4
co-expression in patients with prostate cancer in the Radiation
Therapy Oncology Group (RTOG) 8610. BJU Int. 108:E51–E58. 2011.
View Article : Google Scholar
|
34
|
Sethi G and Tergaonkar V: Potential
pharmacological control of the NF-kappaB pathway. Trends Pharmacol
Sci. 30:313–321. 2009. View Article : Google Scholar : PubMed/NCBI
|
35
|
Kulbe H, Hagemann T, Szlosarek PW,
Balkwill FR and Wilson JL: The inflammatory cytokine tumor necrosis
factor-alpha regulates chemokine receptor expression on ovarian
cancer cells. Cancer Res. 65:10355–10362. 2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wu Y and Zhou BP:
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and
invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Proudfoot AE: Chemokine receptors:
multifaceted therapeutic targets. Nat Rev Immunol. 2:106–115. 2002.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Fernandis AZ, Prasad A, Band H, Klosel R
and Ganju RK: Regulation of CXCR4-mediated chemotaxis and
chemoinvasion of breast cancer cells. Oncogene. 23:157–167. 2004.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Murphy PM: Chemokines and the molecular
basis of cancer metastasis. N Engl J Med. 345:833–835. 2001.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Schioppa T, Uranchimeg B, Saccani A, et
al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp
Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
|
41
|
Karin M: NF-kappaB and cancer: mechanisms
and targets. Mol Carcinog. 45:355–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
42
|
Esencay M, Newcomb EW and Zagzag D: HGF
upregulates CXCR4 expression in gliomas via NF-kappaB: implications
for glioma cell migration. J Neurooncol. 99:33–40. 2010. View Article : Google Scholar : PubMed/NCBI
|